Loading...

Lexaria Bioscience's Breakthrough with DehydraTECH to Revolutionize Drug Delivery

Published
26 Jan 26
Views
0
n/a
n/a
InvestingNurse's Fair Value
n/a
Loading
1Y
-50.9%
7D
12.0%

Author's Valuation

US$5.5584.7% undervalued intrinsic discount

InvestingNurse's Fair Value